Lazard International Strategic Equity Portfolio R6
Lazard International Strategic Equity Portfolio R6 Fundamental Analysis
Lazard International Strategic Equity Portfolio R6 (RLITX) shows moderate financial fundamentals with a PE ratio of 0.00, profit margin of 7.47%, and ROE of 17.91%. The company generates N/A in annual revenue with N/A year-over-year growth of N/A.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 53.9/100 based on profitability, valuation, growth, and balance sheet metrics. The C grade reflects average fundamentals, with notable risks in certain areas.
Fundamental Health Score
We analyze RLITX's fundamental strength across five key dimensions:
Efficiency Score
ExcellentRLITX demonstrates superior asset utilization.
Valuation Score
ExcellentRLITX trades at attractive valuation levels.
Growth Score
ModerateRLITX shows steady but slowing expansion.
Financial Health Score
ModerateRLITX shows balanced financial health with some risks.
Profitability Score
WeakRLITX struggles to sustain strong margins.
Key Financial Metrics
Is RLITX Expensive or Cheap?
P/E Ratio
RLITX trades at 0.00 times earnings. This suggests potential undervaluation.
PEG Ratio
When adjusting for growth, RLITX's PEG of 0.00 indicates potential undervaluation.
Price to Book
The market values Lazard International Strategic Equity Portfolio R6 at 0.00 times its book value. This may indicate undervaluation.
EV/EBITDA
Enterprise value stands at 41.30 times EBITDA. This signals the market has high growth expectations.
How Well Does RLITX Make Money?
Net Profit Margin
For every $100 in sales, Lazard International Strategic Equity Portfolio R6 keeps $7.47 as profit after all expenses.
Operating Margin
Core operations generate 35.65 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $17.91 in profit for every $100 of shareholder equity.
ROA
Lazard International Strategic Equity Portfolio R6 generates $15.23 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
FCF Per Share
Each share generates $0.00 in free cash annually.
FCF Yield
RLITX converts 1.05% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
0.00
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
0.00
vs 25 benchmark
P/B Ratio
Price to book value ratio
0.00
vs 25 benchmark
P/S Ratio
Price to sales ratio
298.14
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.11
vs 25 benchmark
Current Ratio
Current assets to current liabilities
0.13
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.18
vs 25 benchmark
ROA
Return on assets percentage
0.15
vs 25 benchmark
ROCE
Return on capital employed
0.008
vs 25 benchmark
How RLITX Stacks Against Its Sector Peers
| Metric | RLITX Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 0.00 | 18.86 | Better (Cheaper) |
| ROE | 17.91% | 847.00% | Weak |
| Net Margin | 746.55% | 4202.00% | Weak |
| Debt/Equity | 0.11 | 0.91 | Strong (Low Leverage) |
| Current Ratio | 0.13 | 667.17 | Weak Liquidity |
| ROA | 15.23% | -21543.00% (disorted) | Strong |
RLITX outperforms its industry in 3 out of 6 key metrics, particularly excelling in ROA, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Lazard International Strategic Equity Portfolio R6's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
N/A
Industry Style: Value, Dividend, Cyclical
EPS CAGR
N/A
Industry Style: Value, Dividend, Cyclical
FCF CAGR
N/A
Industry Style: Value, Dividend, Cyclical